Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Phase I Clinical Trial of RC19D2 Cell Injection in the Treatment of Diffuse Large B-cell Lymphoma

Beijing Yongtai Ruike Biotechnology Company Ltd · 2023
ClinicalTrials.gov · Datasets · License: Public Domain · 2023
Open Source ↗
recurrent diffuse large b-cell lymphoma, refractory diffuse large b-cell lymphoma, cd19, car-t, rc19d2, dlbcl, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 831810
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.